Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have received a consensus rating of “Hold” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $3.2125.
DCGO has been the topic of several recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a research note on Monday, December 29th. Canaccord Genuity Group reduced their price objective on shares of DocGo from $1.60 to $1.50 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Finally, Zacks Research raised shares of DocGo from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th.
View Our Latest Report on DCGO
DocGo Price Performance
DocGo (NASDAQ:DCGO – Get Free Report) last released its quarterly earnings results on Monday, November 10th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.02). The firm had revenue of $70.81 million for the quarter, compared to analysts’ expectations of $69.96 million. DocGo had a negative net margin of 14.02% and a negative return on equity of 9.11%. As a group, equities analysts anticipate that DocGo will post 0.25 earnings per share for the current fiscal year.
Institutional Trading of DocGo
Institutional investors have recently added to or reduced their stakes in the stock. CWM LLC lifted its stake in DocGo by 2,613.3% during the second quarter. CWM LLC now owns 21,978 shares of the company’s stock worth $35,000 after purchasing an additional 21,168 shares in the last quarter. Cerity Partners LLC purchased a new stake in shares of DocGo in the 2nd quarter valued at $37,000. Strs Ohio acquired a new position in DocGo during the 1st quarter worth about $76,000. Engineers Gate Manager LP purchased a new position in DocGo during the 2nd quarter valued at about $52,000. Finally, Royce & Associates LP acquired a new position in DocGo in the 3rd quarter valued at about $64,000. Institutional investors and hedge funds own 56.44% of the company’s stock.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Articles
- Five stocks we like better than DocGo
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Buy This Stock at 9:30 AM on MONDAY!
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
